Capital Impact Advisors, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2023$674,723
+48.1%
10,676
+5.4%
0.74%
+32.7%
Q1 2023$455,569
+42.0%
10,126
+38.2%
0.56%
+78.0%
Q4 2022$320,908
+2.9%
7,3250.0%0.31%
+1.0%
Q3 2022$312,000
+3.0%
7,325
+22.0%
0.31%
+11.1%
Q2 2022$303,000
-43.6%
6,005
-28.6%
0.28%
-28.4%
Q1 2022$537,000
-34.6%
8,411
+9.7%
0.39%
-30.9%
Q4 2021$821,0007,6670.57%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders